Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 USD | +0.24% | +2.67% | -12.12% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.12% | 2.45B | |
+4.60% | 111B | |
+11.59% | 105B | |
-12.86% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.07% | 16.96B | |
+3.54% | 13.7B | |
+38.18% | 12.45B |
- Stock Market
- Equities
- RYTM Stock
- News Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals Doses First Patients in Phase 1 Trial of Potential Obesity Therapy